These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38260797)

  • 1. Uncovering transcriptomic biomarkers for enhanced diagnosis of methamphetamine use disorder: a comprehensive review.
    Jang WJ; Lee S; Jeong CH
    Front Psychiatry; 2023; 14():1302994. PubMed ID: 38260797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Potential Biomarkers for Diagnosis of Patients with Methamphetamine Use Disorder.
    Jang WJ; Song SH; Son T; Bae JW; Lee S; Jeong CH
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and Emerging Treatments for Methamphetamine Use Disorder.
    Moszczynska A
    Curr Neuropharmacol; 2021; 19(12):2077-2091. PubMed ID: 34344291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in clinical features and gut microbiota between individuals with methamphetamine casual use and methamphetamine use disorder.
    He L; Yang BZ; Ma YJ; Wen L; Liu F; Zhang XJ; Liu TQ
    Front Cell Infect Microbiol; 2023; 13():1103919. PubMed ID: 36909722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
    Stauffer CS; Moschetto JM; McKernan SM; Hsiang E; Borsari B; Woolley JD
    Trials; 2019 Feb; 20(1):145. PubMed ID: 30791944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatments for methamphetamine addiction: current status and future directions.
    Ballester J; Valentine G; Sofuoglu M
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):305-314. PubMed ID: 27927042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota as a potential biomarker for methamphetamine use disorder: evidence from two independent datasets.
    Liu L; Deng Z; Liu W; Liu R; Ma T; Zhou Y; Wang E; Tang Y
    Front Cell Infect Microbiol; 2023; 13():1257073. PubMed ID: 37790913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the tip of the iceberg: A narrative review to identify research gaps on comorbid psychiatric disorders in adolescents with methamphetamine use disorder or chronic methamphetamine use.
    Kuitunen-Paul S; Roessner V; Basedow LA; Golub Y
    Subst Abus; 2021; 42(1):13-32. PubMed ID: 32870121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of executive function and age of first use of methamphetamine with methamphetamine relapse.
    Mu LL; Wang Y; Wang LJ; Xia LL; Zhao W; Song PP; Li JD; Wang WJ; Zhu L; Li HN; Wang YJ; Tang HJ; Zhang L; Song X; Shao WY; Zhang XC; Xu HS; Jiao DL
    Front Psychiatry; 2022; 13():971825. PubMed ID: 36311529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature.
    Hamel C; Corace K; Hersi M; Rice D; Willows M; Macpherson P; Sproule B; Flores-Aranda J; Garber G; Esmaeilisaraji L; Skidmore B; Porath A; Ortiz Nunez R; Hutton B
    Syst Rev; 2020 Oct; 9(1):245. PubMed ID: 33099314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis among individuals with methamphetamine use disorder is associated with elevated rates of hospitalizations and emergency department visits across an academic health care system.
    Zito MF; Fei Z; Zhu Y; Clingan SE; Marder SR; Mooney LJ
    J Subst Use Addict Treat; 2023 Aug; 151():209033. PubMed ID: 37011880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A brainnetome atlas-based methamphetamine dependence identification using neighborhood component analysis and machine learning on functional MRI data.
    Zhou Y; Tang J; Sun Y; Yang WFZ; Ma Y; Wu Q; Chen S; Wang Q; Hao Y; Wang Y; Li M; Liu T; Liao Y
    Front Cell Neurosci; 2022; 16():958437. PubMed ID: 36238830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired social decision-making in males with methamphetamine use disorder.
    Li MH; Zhang M; Yuan TF; Rao LL
    Addict Biol; 2022 Sep; 27(5):e13204. PubMed ID: 36001418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults.
    Han B; Compton WM; Jones CM; Einstein EB; Volkow ND
    JAMA Psychiatry; 2021 Dec; 78(12):1329-1342. PubMed ID: 34550301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with Methamphetamine Use Disorder Show Highly Utilized Proactive Inhibitory Control and Intact Reactive Inhibitory Control with Long-Term Abstinence.
    Dai W; Zhou H; Møller A; Wei P; Hu K; Feng K; Han J; Li Q; Liu X
    Brain Sci; 2022 Jul; 12(8):. PubMed ID: 35892415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Landscape of Methamphetamine Use Disorder.
    Cadet JL; Jayanthi S
    Curr Neuropharmacol; 2021; 19(12):2060-2066. PubMed ID: 34030618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations and relative risks of pulmonary hypertension and lung diseases in individuals with methamphetamine use disorder.
    Fang SC; Huang CY; Huang SM; Shao YJ
    Pulmonology; 2023 Mar; ():. PubMed ID: 36907811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verbal learning impairment in adolescents with methamphetamine use disorder: a cross-sectional study.
    Basedow LA; Kuitunen-Paul S; Wiedmann MF; Ehrlich S; Roessner V; Golub Y
    BMC Psychiatry; 2021 Mar; 21(1):166. PubMed ID: 33765981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcranial direct current stimulation over prefrontal cortex combined with the cognitive training reduced the cue-induced craving in female individuals with methamphetamine use disorder: A randomized controlled trial.
    Xu X; Ding X; Chen L; Chen T; Su H; Li X; Ye Y; Shi W; Ji J; Zhao M; Zhong N; Jiang H
    J Psychiatr Res; 2021 Feb; 134():102-110. PubMed ID: 33383492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.